The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies

QR Code

The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies

© 2018 by the authors. Licensee MDPI, Basel, Switzerland. Signal transducer and activator of transcription 3 (STAT3), a member of the STAT protein family, can be phosphorylated by receptor-associated Janus kinases (JAKs) in response to stimulation by cytokines and growth factors. It forms homo-or he...

Full description

Bibliographic Details
Main Authors:	Arora, L., Kumar, Alan Prem, Arfuso, Frank, Chng, W., Sethi, G.
Format:	Journal Article
Published:	MDPI AG 2018
Online Access:	http://hdl.handle.net/20.500.11937/72647

Similar Items

Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma
by: Subramaniam, A., et al.
Published: (2012)

Targeting transcription factor STAT3 for cancer prevention and therapy.
by: Chai, E., et al.
Published: (2015)

Development of a novel azaspirane that targets the Janus Kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo
by: Mohan, C., et al.
Published: (2014)

Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies
by: Wong, A., et al.
Published: (2015)

Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo
by: Rajendran, P., et al.
Published: (2011)

Negative regulation of signal transducer and activator of transcription-3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells
by: Siveen, K., et al.
Published: (2014)

Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1
by: Rajendran, P., et al.
Published: (2012)

Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
by: Siveen, K., et al.
Published: (2013)

Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3
by: Dai, X., et al.
Published: (2015)

Signal Transducer and Activator of Transcription 3 - a promising target in colitis-associated cancer
by: Pandurangan, Ashok Kumar, et al.
Published: (2014)

Evaluation of signal transducer and activator of transcription 3 (STAT-3) protein expression in non-hodgkin lymphoma cases in Hospital Universiti Sains Malaysia
by: Muhamad, Izyan Rifhana
Published: (2023)

Nimbolide-induced oxidative stress abrogates STAT3 signaling cascade and inhibits tumor growth in transgenic adenocarcinoma of mouse prostate model
by: Zhang, J., et al.
Published: (2016)

Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model
by: Shanmugam, M., et al.
Published: (2015)

Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer
by: Zhang, J., et al.
Published: (2017)

Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model
by: Kim, C., et al.
Published: (2018)

Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
by: Singh, S., et al.
Published: (2015)

Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
by: Subramaniam, A., et al.
Published: (2013)

Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo
by: Sethi, G., et al.
Published: (2014)

Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
by: Kannaiyan, R., et al.
Published: (2011)

Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcoma
by: Wang, X., et al.
Published: (2016)

Potential role of PKC inhibitors in the treatment of hematological malignancies
by: Mischiati, C., et al.
Published: (2008)

The STAT3-Ser/Hes3 signaling axis in cancer
by: Poser, Steven, et al.
Published: (2014)

STAT2 is a pervasive cytokine regulator due to its inhibition of STAT1 in multiple signaling pathways
by: Ho, Johnathan, et al.
Published: (2016)

STAT2 is a pervasive cytokine regulator due to its inhibition of STAT1 in multiple signaling pathways
by: Ho, Johnathan, et al.
Published: (2016)

Targeting the ubiquitin pathway in lymphoid malignancies
by: Li, Boheng, et al.
Published: (2024)

γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: Potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent
by: Rajendran, P., et al.
Published: (2011)

Targeting PPARy signaling cascade for the prevention and treatment of prostate cancer
by: Sikka, S., et al.
Published: (2012)

Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma
by: Sibbesen, Nina A., et al.
Published: (2015)

Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade In Vitro and In Vivo
by: Rajendran, P., et al.
Published: (2012)

Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt-ß-catenin-mediated intestinal tumor growth and regeneration
by: Phesse, T., et al.
Published: (2014)

STAT3-Ser/Hes3 signaling: a new molecular component of the neuroendocrine system?
by: Nikolakopoulou, P., et al.
Published: (2016)

Molecular targets and anti-cancer potential of escin
by: Cheong, D., et al.
Published: (2018)

Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer
by: Shanmugam, M., et al.
Published: (2012)

Do STAT3 inhibitors have potential in the future for cancer therapy?
by: Wong, A., et al.
Published: (2017)

The identification of STAT2 as a pervasive negative regulator of STAT1 activity and cytokine signalling
by: Ho, Johnathan
Published: (2018)

Unphosphorylated dimers are not required for the assembly of active STAT1 and STAT3 homo-and heterodimers
by: Krause, Sebastian C.
Published: (2023)

Wnt Signalling in Malignant Mesothelioma
by: Richards, Alexander S.K.
Published: (2016)

LRG1 promotes metastatic dissemination of melanoma through regulating EGFR/STAT3 signalling
by: Kwan, Yuet Ping, et al.
Published: (2021)

Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn
by: Shanmugam, M., et al.
Published: (2018)

Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn
by: Shanmugam, M., et al.
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jt2umjkqan1e83tgr645pqv5ig